181 related articles for article (PubMed ID: 26817957)
41. Occult cancer in patients with venous thromboembolism: which patients, which cancers.
Monreal M; Fernandez-Llamazares J; Perandreu J; Urrutia A; Sahuquillo JC; Contel E
Thromb Haemost; 1997 Nov; 78(5):1316-8. PubMed ID: 9408011
[TBL] [Abstract][Full Text] [Related]
42. [Screening for cancer in case of venous thromboembolism: when and how?].
Sevestre MA
Rev Prat; 2022 Mar; 72(3):267-269. PubMed ID: 35638947
[TBL] [Abstract][Full Text] [Related]
43. Implementation of NICE recommendations on abdomino-pelvic CT, following unprovoked venous thromboembolism, in a UK teaching hospital: no additional detection of occult malignancy and high numbers of incidental findings.
Garwood D; Renton BJ; Joekes E
Acute Med; 2016; 15(5):25-9. PubMed ID: 27116584
[TBL] [Abstract][Full Text] [Related]
44. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Lacut K; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Le Gal G; Salaun PY
PLoS One; 2017; 12(6):e0178849. PubMed ID: 28570648
[TBL] [Abstract][Full Text] [Related]
45. Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
Zhou M; Zhang L; Ding Y; Wang Y; Yan D; Lin C; Shi Z; Fu W
Thromb Res; 2017 Sep; 157():147-153. PubMed ID: 28753478
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
[TBL] [Abstract][Full Text] [Related]
47. Unprovoked venous thromboembolism in women over 40: is screening for occult malignancy with mammography and abdominopelvic CT of benefit?
Healy NA; Daley FC; Sinnatamby R
Clin Radiol; 2020 Oct; 75(10):757-762. PubMed ID: 32646605
[TBL] [Abstract][Full Text] [Related]
48. [Not Available].
Šarinayová S
Praxis (Bern 1994); 2018 Feb; 107(5):271-275. PubMed ID: 29486646
[No Abstract] [Full Text] [Related]
49. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study.
Enga KF; Braekkan SK; Hansen-Krone IJ; le Cessie S; Rosendaal FR; Hansen JB
J Thromb Haemost; 2012 Oct; 10(10):2068-74. PubMed ID: 22882779
[TBL] [Abstract][Full Text] [Related]
50. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
51. Cancer and venous thrombosis: current comprehensions and future perspectives.
Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
[TBL] [Abstract][Full Text] [Related]
52. ACP Journal Club: adding CT to screening for occult cancer did not increase diagnosis of cancer from screening in unprovoked VTE.
Schreiber R
Ann Intern Med; 2015 Nov; 163(10):JC9. PubMed ID: 26571263
[No Abstract] [Full Text] [Related]
53. CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
Lee RJ; Herlihy D; O'Neill DC; Madden-Doyle L; Morrin M; Lee MJ
Ir J Med Sci; 2023 Dec; 192(6):3081-3086. PubMed ID: 36849651
[TBL] [Abstract][Full Text] [Related]
54. Venous thromboembolism and cancer risk.
Sandén P; Svensson PJ; Själander A
J Thromb Thrombolysis; 2017 Jan; 43(1):68-73. PubMed ID: 27522504
[TBL] [Abstract][Full Text] [Related]
55. Investigation of unprovoked venous thromboembolism: a case for a tempered approach?
Hussain TI; Stephenson JA; Das B; Naqvi S; Verma R; Barnes D
Clin Radiol; 2016 Oct; 71(10):1005-1009. PubMed ID: 27237325
[TBL] [Abstract][Full Text] [Related]
56. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
57. Screening for occult cancer in idiopathic venous thromboembolism - Systemic review and meta-analysis.
Klein A; Shepshelovich D; Spectre G; Goldvaser H; Raanani P; Gafter-Gvili A
Eur J Intern Med; 2017 Jul; 42():74-80. PubMed ID: 28502867
[TBL] [Abstract][Full Text] [Related]
58. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.
Rinde LB; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Hald EM; Wilsgaard T; Brækkan SK; Hansen JB
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821402
[TBL] [Abstract][Full Text] [Related]
59. Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
Kohn CG; Bunz TJ; Beyer-Westendorf J; Coleman CI
Eur J Haematol; 2019 Feb; 102(2):143-149. PubMed ID: 30328143
[TBL] [Abstract][Full Text] [Related]
60. Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry.
Trujillo-Santos J; Prandoni P; Rivron-Guillot K; Román P; Sánchez R; Tiberio G; Monreal M;
J Thromb Haemost; 2008 Feb; 6(2):251-5. PubMed ID: 18021305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
